Father and Son 982x327px

Fuel Our Fight

ACKC is the only major
kidney cancer grassroots
advocacy organization
raising money that goes
predominantly to fund
kidney cancer research

Donate Today
Capitol 982x327px

Annual Campaign
for Federal
Research Funding

ACKC's Capitol Hill initiative
to get a $15M appropriation
for kidney cancer research

Sign Up for 2017
Researcher A 982x327px

Direct Funding
to Kidney Cancer

Since 2006, ACKC has
granted more than $350,000
to promising researchers

Learn More
Man with MD 982 x 327px

Advocacy for
Special Funding

ACKC’s work on Capitol Hill
resulted in increased support
for federal research projects.

Learn More
Holding Hand 982x327px

Patient Guides:
Taking Charge of
Kidney Cancer

Updated in 2016, ACKC’s
online pamphlets empower
patients and their caregivers

View the Guides
Slide background

Stay Connected

Join ACKC’s online
community of survivors,
caregivers, family and
friends by liking us
on Facebook…we’re
13,049 members strong!

Join Us Online

ACKC Point of View


  • Remembering Fred Atkin

    November 7, 2017

    Fred Atkin, a charter member and Vice President of ACKC since 2002, passed away unexpectedly on October 30th. He was 79 years old. He is survived by his wife, Joyce, sons, Todd and Billy, sister, Joyce, and grandson, Alex. As a leader in ACKC’s effort to obtain DoD funding for kidney cancer research, Fred traveled to Washington, D.C. each year to meet with Congressional legislators and staff and organized our yearly Lobbying Days each spring…. More →

  • Senate Passes FDA Bill

    September 1, 2017

    Shortly before the U.S. Senate left for an undeserved paid vacation, they passed a flurry of minor bills including funding for the Food and Drug Administration, the FDA Reauthorization Act, by a vote of 94-1, and the Right to Try Act, which enables terminally ill patients to have access to investigational drugs, outside of the clinical trial process. An FDA-funding bill was previously passed by the House, while the Right to Try Act will now… More →

  • Symptom Monitoring Increases Survival

    July 20, 2017

    The results of a randomized trial of patient-reported symptom monitoring during cancer treatment is shown to increase overall survival and Quality of Life over standard care according to a presentation given by Ethan Basch, of the University of North Carolina, at a plenary session of the Association of Clinical Oncology annual conference this June. Go to http://www.ackc.org/symptom-monitoring-increases-survival/  to see the full trial summary.

  • Support for Kidney Cancer Funding

    June 26, 2017

    In March 2017, the president signed the Consolidate Appropriations Act for FY2017, which called for a $10 million appropriation for kidney cancer research as part of the Congressionally Directed Medical Research Programs (CDMRP), managed by the Department of Defense. This past spring, ACKC lobbied for a continuation of kidney cancer’s $10 million funding for FY2018, which commences September 1st. CDMRP encompasses around 18 cancer types with most of them falling under the $60 million Peer… More →

  • MAJOR VICTORY – $10 Million for Kidney Cancer Research!!!

    May 7, 2017

    Congress passed, and on May 5, the President signed the Consolidated Appropriations ACT for Fiscal Year 2017, which includes a $10 million line item for kidney cancer research under the Congressionally Directed Medical Research Programs (CDMRP). This represents the largest increase ever in the federal budget for kidney cancer research. View Our Video   Kidney cancer strikes 64,000 Americans each year, and over 14,400 succumb to the disease. The $10 million will provide a shot… More →